|
Krebs Biochemicals & Industries Limited (KBIL) was incorporated in the year 1991 as a Public
Limited Company with the main objective of establishing commercially viable biotech processes
with applications in Medicine, Agriculture Industry. The company has pioneered in the
fermentation technology over the last decade. KBIL went into public in the year March 1994 to
part finance its fermentation technology project. KBIL has a strong shareholding community of
over 10000 spread across all parts of the country. Presently the equity shares are listed on HSE,
BSE and NSE with active trading on BSE.
KBIL has manufacturing facilities at Ragadichelika, Nellore (Unit I) and at Kothapalli Village,
Kasimkota Mandal, Visakhapatnam District (Unit II). Products manufactured from Unit I facility
are Ephedrine, Pseudoephedrine and their salts, which are used for making formulations for
respiratory ailments, viz., cough, cold etc. The facility at Unit II is being used to manufacture a basket of fermentation products viz., Lovastatin, Simvastatin, (all cholesterol reducing agents) and Vitamin C and its salts (neutraceuticals), which has wider applications in Pharma, feeds, foods beverages etc. The company is focussing on the research and development of new bio molecules and genetically engineered products by synthetic and biological approaches. The R&D centres of KBIL situated at Unit I and ICICI Knowledge Park, Hyderabad are recognized by DSIR, New Delhi. The growth of KBIL is strengthened by its work force consisting of Doctorates, Post Graduates, Technocrats etc.
|
